January 27, 2020 Real Estate Publication

White House claims Pelosi’s drug pricing bill would result in 100 fewer drugs over decade

The U.S. Speaker of the House Nancy Pelosi speaks over impeachment inquiry two days after the formal request during her weekly press conference on Capitol Hill on Thursday, September 26, 2019.

Aurora Samperio | NurPhoto | Getty Images

Democratic House Speaker Nancy Pelosi‘s sweeping drug pricing bill would result in as many as 100 fewer drugs hitting the U.S. market over the next decade, the White House claimed in a report Tuesday.

The White House, citing an analysis from the Council of Economic Advisers, an agency within the executive office, also said Pelosi’s bill would lead to worse health outcomes and cost the U.S. economy $1 trillion per year over that time period.

The report from the administration, which has some health policy analysts scratching their heads, suggests far greater consequences than other estimates for both the drug industry and American consumers if the bill is enacted.

The main thrust of Pelosi’s plan will allow the Department of Health and Human Services to negotiate lower prices on the costliest drugs each year.

In October, the Congressional Budget Office, an independent agency that reviews congressional spending, estimated Pelosi’s bill would produce $345 billion in savings if enacted. It also said the bill would lead to a reduction of eight to 15 new drugs entering the U.S. market. That’s because pharmaceutical companies would make less revenue under the rules, resulting in them cutting R&D spending for new drugs, the CBO said.

However, the White House suggested Tuesday that the CBO was wrong in its analysis and said other studies may show that Pelosi’s bill may have far greater consequences for American consumers.

Pelosi’s bill “may share the Trump Administration’s first goal of lowering prices, but the threat it poses to continued medical innovation will harm American patients in ways that far outweigh any benefits,” the White House said in a blog post.

Gerard Anderson, professor of health policy and management at Johns Hopkins University, said he didn’t buy the administration’s argument in a drastic reduction of new drugs.

Pharmaceutical companies “would shoot themselves in the foot if they didn’t develop new drugs,” Anderson told CNBC on Tuesday. “They have to keep the pipeline going to have a market for selling anything.”

The White House report comes as Congress and President Donald Trump try to pass legislation before the end of the year that would lower health-care costs for consumers. High prescription drug costs have become a rare bipartisan issue, as health care remains a top issue for voters ahead of the 2020 presidential election.

Earlier this year, Pelosi said she hoped to work with Trump on a bill to lower drug prices even after launching an impeachment inquiry. In response, Trump accused Pelosi of trying to distract voters.

In a statement Tuesday, a spokesman for Pelosi said the White House has “proven again and again” that it cannot be trusted to provide “accurate numbers or honest analysis.”

“President Trump’s CEA has written a love letter to Big Pharma and letting out-of-control drug prices continue just the way they are,” spokesman Henry Connelly said.

In the Senate, Finance Committee Chairman Chuck Grassley, R-Iowa, and ranking Democrat Ron Wyden, of Oregon, have introduced their own bipartisan drug price bill that is backed by Trump. Grassley told reporters weeks ago that he would introduce a “revamped” version of his bill aimed at gaining more Republican support.

Meantime, Pelosi is awaiting the final review from the CBO on her bill. That is expected to come out later this month, according to a senior Democratic aide.

Related Posts

Silicon Valley remembers Clayton Christensen, ‘godfather of disruptive innovation’

January 27, 2020

January 27, 2020

Clayton M. Christensen John Lamparski/Getty Images Harvard Business School professor and businessman Clayton Christensen, known by many as the “godfather”...

Coronavirus prompts automakers to evacuate workers, weigh production delays at Chinese factories

January 27, 2020

January 27, 2020

Laborers work in the Qingdao branch of SAIC-GM-Wuling Automobile in Qingdao, China. STR | AFP | Getty Images Automakers are...

Boeing secures more than $12 billion in financing to help weather 737 Max crisis

January 27, 2020

January 27, 2020

Boeing 737 MAX airplanes, along with one Boeing 787 at top, are parked at Grant County International Airport October 23,...

Oil tumbles into bear market, hits more than 3-month low on fears coronavirus will slow global growth

January 27, 2020

January 27, 2020

A staff member checks the temperature of a guest entering the casino of the New Orient Landmark hotel in Macau...

Coronavirus fears send stocks lower—what Cramer and other Wall Street pros are watching

January 27, 2020

January 27, 2020

Fears around China’s coronavirus outbreak are in full force. The concern put meaningful pressure on the major averages Monday, sending...

High-speed traders cost regular investors almost $5 billion a year, study says

January 27, 2020

January 27, 2020

A trader works on the floor of the New York Stock Exchange. Getty Images Traders and hedge funds who use...

The stock market is starting to worry about Bernie Sanders

January 27, 2020

January 27, 2020

2020 Democratic presidential candidate U.S. Sen. Bernie Sanders (I-VT) speaks during a rally at the Iowa State Fairgrounds on March...

Bath & Body Works’ owner could see sales of hand sanitizer and soap rise as deadly coronavirus spreads

January 27, 2020

January 27, 2020

Roberto Machado Noa | LightRocket | Getty Images Bath & Body Works owner L Brands could be poised to benefit...

US companies suspend China operations, restrict travel as coronavirus outbreak spreads

January 27, 2020

January 27, 2020

A militia member checks the body temperature of a driver on a vehicle at an expressway toll gate in Wuhan...

Fugitive ex-Nissan Chairman Carlos Ghosn warns foreign CEOs in Japan: ‘You’re playing with your life’

January 27, 2020

January 27, 2020

Three weeks after he escaped from Japan, former Nissan Chairman and CEO Carlos Ghosn is relishing his newfound freedom and...

China coronavirus death toll climbs to 82 with at least 2,900 cases worldwide

January 27, 2020

January 27, 2020

A novel coronavirus has now taken the lives of at least 82 people in China and sickened at least 2,900...

Coronavirus shutters restaurants in China, sending shares of Luckin, Starbucks lower

January 27, 2020

January 27, 2020

Wary of the coronavirus, crowds of people wear surgical masks. In light of a deadly virus outbreak in China, Hong...

CDC is monitoring 110 possible coronavirus cases across 26 states in US

January 27, 2020

January 27, 2020

U.S. health officials are currently monitoring 110 people across 26 states for the coronavirus, including the five patients who contracted...

Athletes pay tribute to Kobe Bryant. Michael Jordan says: ‘He was like a little brother to me’

January 27, 2020

January 27, 2020

Kobe Bryant #24 of the Los Angeles Lakers looks on against the Washington Wizards in the first half at Verizon...

Here’s why the stock market may be overreacting to the coronavirus threat

January 27, 2020

January 27, 2020

The continued spread of the coronavirus appears to be hitting global markets like a similar outbreak in 2003, but the...